Himawari (satellites)

Electronic Skin Patches: Transforming Everyday Life, Says IDTechEx

Retrieved on: 
Monday, March 20, 2023
CGM, Communication, Holter, Life, Diabetes, Workplace, Radiation monitoring, Ovulation, Skin, Record, Temperature, Attention, Biomarker, PepsiCo, Athlete, Thermoregulation, Heat injury, Vital signs, Patient, Risk, Fertility, Sport, Himawari (satellites), GX, Heart rate, Health, BBT, Perspiration, Gatorade, Medical device, Cosmetics, Birth control, Epicor

The combined value of cardiac and diabetes applications is estimated to be worth US$13.2 billion, according to IDTechEx in their recent report " Electronic Skin Patches 2023-2033 ".

Key Points: 
  • The combined value of cardiac and diabetes applications is estimated to be worth US$13.2 billion, according to IDTechEx in their recent report " Electronic Skin Patches 2023-2033 ".
  • This article delves into the exciting potential of electronic skin patches in shaping everyday life.
  • As it stands, electronic skin patches have found great success in healthcare applications such as cardiac rhythm and blood glucose monitoring, while the consumer market for electronic skin patches has been smaller and challenging to navigate.
  • Overall, the consumer market for electronic skin patches is expected to grow, and in their report " Electronic Skin Patches 2023-2033 ", IDTechEx predicts that temperature sensing will be the fastest growing area, with a CAGR of 26.5%.

Global AI in Diabetes Management Market to 2027: Players Include Abbott, Bigfoot Biomedical, Cardinal Health, Dreamed Diabetes and Eyenuk - ResearchAndMarkets.com

Retrieved on: 
Monday, March 20, 2023
Technology, Diabetes, Health, Artificial Intelligence, Insulin, Smartphone, Self-management, Blood, Data analysis, COVID-19, Patient, Artificial intelligence, Himawari (satellites), AI, Medical device

The use of AI aids in the detection and prediction of diabetes.

Key Points: 
  • The use of AI aids in the detection and prediction of diabetes.
  • In this report, the global market for AI in diabetes management has been segmented based on product type, technique and geographic region.
  • By product type, the market for AI in diabetes management is categorized into glucose monitoring devices, diagnostic devices, and insulin delivery devices.
  • North America is currently the leading region in the global market for AI in diabetes management.

Levels Secures $7M Series A Extension Funding to Solve Metabolic Health Crisis

Retrieved on: 
Tuesday, January 31, 2023
Technology, Hospitals, Diabetes, Fitness & Nutrition, Software, Biotechnology, Managed Care, General Health, Pharmaceutical, Health, Biomarker, Science, Sleep, Health (Apple), Food industry, Empowerment, Trust, Prediabetes, Food, Death, Blog, Disease, Education, Exercise, Multimedia, Himawari (satellites), Cryptocurrency, Medical device, Level

Levels , a software company that provides real-time feedback on how food affects your health, announced today $7 million in series A extension funding.

Key Points: 
  • Levels , a software company that provides real-time feedback on how food affects your health, announced today $7 million in series A extension funding.
  • Levels helps people see how food affects their health via a mobile application that leverages data from biosensors and other sources, such as Apple Health.
  • (Photo: Business Wire)
    To date, Levels has raised more than $55 million to solve the metabolic health crisis.
  • Levels’ mission is to solve the metabolic health crisis by increasing accessibility to biomarkers, like real-time glucose, which are known to affect our health and risk of disease.

Dario Partners to Integrate Dexcom CGM Data

Retrieved on: 
Wednesday, February 8, 2023
Sanofi, Ecosystem, Diabetes, Health, Single-frequency network, CGM, DXCM, Himawari (satellites), Medical device, Pharmaceutical industry, Dexcom

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today an agreement with Dexcom (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring (CGM) technology, to integrate its market-leading CGMs, into Dario's multi-chronic condition platform.

Key Points: 
  • Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health.
  • This agreement enables the integration of data from Dexcom CGMs directly into Dario's metabolic solution, making it easy for people using the wearable device to benefit from Dario's highly personalized support.
  • It's an exciting development that will ultimately benefit every Dario member as the CGM data enriches our overall data ecosystem," said Rick Anderson, President of Dario.
  • The integration with Dexcom builds on the collaboration between Dario and Sanofi US which aims to establish an ecosystem of dedicated technology partners and industry-leading digital therapeutics solutions.

Continuous Glucose Monitoring Fosters Blood Glucose Meters Industry Growth - Grand View Research, Inc.

Retrieved on: 
Wednesday, February 8, 2023
Benchmarking, CGM, Himawari (satellites), Traction, Insulin, Pan American Health Organization, Dexcom, Diagnosis, Innovation, Blood, POCT, Hypoglycemia, Diabetes, Blood sugar level, Red Data Book of the Russian Federation, POC, CDC, Intelligence, USD, Continuous glucose monitor, Disease, SAN, R, Self-management, COVID-19, PAHO, Abbott, Medical device, Retail, Pharmaceutical industry

An unprecedented rise in the diabetic population has furthered the demand for technologies monitoring blood glucose.

Key Points: 
  • An unprecedented rise in the diabetic population has furthered the demand for technologies monitoring blood glucose.
  • Blood glucose monitoring devices have witnessed increased traction across developing and developed countries, mainly due to the need to stay on track with blood sugar goals.
  • The growth trajectory is primarily attributed to the trend for continuous glucose monitoring (CGM) technologies to track blood sugar levels.
  • Blood glucose meters manufacturers and suppliers are expected to cash in on the prevailing growth potentials to expand their penetration across yet-to-be-penetrated areas.

Continuous Glucose Monitoring Fosters Blood Glucose Meters Industry Growth - Grand View Research, Inc.

Retrieved on: 
Wednesday, February 8, 2023
Benchmarking, CGM, Himawari (satellites), Traction, Insulin, Pan American Health Organization, Dexcom, Diagnosis, Innovation, Blood, POCT, Hypoglycemia, Diabetes, Blood sugar level, Red Data Book of the Russian Federation, POC, CDC, Intelligence, USD, Continuous glucose monitor, Disease, SAN, R, Self-management, COVID-19, PAHO, Abbott, Medical device, Retail, Pharmaceutical industry

An unprecedented rise in the diabetic population has furthered the demand for technologies monitoring blood glucose.

Key Points: 
  • An unprecedented rise in the diabetic population has furthered the demand for technologies monitoring blood glucose.
  • Blood glucose monitoring devices have witnessed increased traction across developing and developed countries, mainly due to the need to stay on track with blood sugar goals.
  • The growth trajectory is primarily attributed to the trend for continuous glucose monitoring (CGM) technologies to track blood sugar levels.
  • Blood glucose meters manufacturers and suppliers are expected to cash in on the prevailing growth potentials to expand their penetration across yet-to-be-penetrated areas.